Gene Query: UTP11

Dataset Description Geneva Score
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 49.71
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 40.52
HEXIM1 is induced by DHODH inhibition to suppress melanoma 37.49
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 37.49
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 27.56
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 25.39
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 25.39
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 22.07
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 19.26
FBXW7 modulates stress response by post-translational modification of HSF1 16.57
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 16.57
HNF1A deficiency impairs β-cell fate, granule maturation and function 16.13
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 15.46
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 14.79
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 14.78
Transcriptome of human white and brown adipose tissue biopsies 13.75
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 13.01
Global expression profiles in cardiac progenitor cells generated by ISX-9 12.98
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 12.98
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.98
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 12.9
Developmental stage specific chromosome architecture in human erythroid cells 12.76
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 12.76
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 12.58
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 12.18
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 12.15
A transcriptome-wide divergence in protein translation scales with LIN28B expression 12.15
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 12.03
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 11.98
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 11.87
Global analysis of enhancer targets: Mosaic-seq 11.84
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 11.74
DART-seq: an antibody-free method for global m6A detection 11.51
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 11.41
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 11.41
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 11.39
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.3
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 10.67
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 10.67
Transcriptome of activated human and mouse MAIT cells 10.55
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 10.45
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 10.39
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 10.36
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 10.33
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 10.25
LNCaP treated with iBET 10.22
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 10.13
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 10.09
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 9.94
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 9.85
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 9.78
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 9.78
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 9.77
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 9.62
RNA m5C Methylation in breast cancer using MeRIP-Seq 9.59
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 9.48
Cajal bodies are linked to genome conformation [RNA-Seq] 9.24
Cajal bodies are linked to genome conformation 9.24
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 9.11
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 9.09
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 9.09
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 8.99
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 8.9
The pause-initiation limit restricts transcription activation in human cells 8.59
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.58
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 8.48
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.47
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.47
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 8.39
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 8.37
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.34
Noncoding regions are the main source of targetable tumor-specific antigens 8.29
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 8.24
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 8.2
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 8.13
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 8.09
scRNASeq analysis of cycling cardiomyocytes 8.06
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.05
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 8.04
Functional role of SLIT2 and ROBO1 in trophoblasts 7.99
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 7.99
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 7.99
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.97
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 7.95
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.94
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 7.93
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 7.93
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 7.9
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 7.9
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.88
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.67
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.67
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 7.61
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 7.57
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML 7.52
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 7.45
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.44
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 7.4
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 7.4
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.4
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 7.34
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 7.33
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 2h] 7.19
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 7.16
CROP-Seq in Primary Human T Cells 7.16
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.11
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 7.09
Identification of transcription start sites for human A549 cell line using ReCappable-seq 7.0
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.93
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.91
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 6.81
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 6.81
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 6.75
Global Mapping of Human RNA-RNA Interactions 6.75
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 6.74
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 6.73
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 6.73
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.71
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 6.66
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 6.66
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 6.63
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 6.62
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 6.62
Transcription control by the ENL YEATS domain in acute leukemia 6.6
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.6
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 6.56
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 6.56
Transcriptomic analysis of human tonsillar TFH subsets 6.56
Systematic discovery of endogenous human ribonucleoprotein complexes 6.56
Effect of PBK knockdown on C4-2 cell transcriptome 6.54
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.53
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.53
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 6.48
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.47
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.46
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 6.43
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 6.42
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 6.41
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.4
Capturing the Interactome of Newly Transcribed RNA 6.34
Capturing the Interactome of Newly Transcribed RNA (RICK) 6.34
RNA-seq of resting and activated CD4+ T cells +-JQ1 6.34
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 6.33
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 6.31
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.28
R430: A potent inbibitor of DNA and RNA viruses 6.24
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.23
The landscape of alternative splicing in aggressive prostate cancers 6.2
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 6.2
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 6.18
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.18
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 6.11
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 6.11
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 6.1
Effect of disulfiram treatment on pediatric high grade glioma 6.08
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 6.01
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.98
Lysine benzoylation is a novel histone mark 5.97
Lysine benzoylation is a novel histone mark [RNA-seq] 5.97
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 5.97
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 5.97
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 5.93
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 5.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.88
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.87
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.87
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.86
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 5.84
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 5.84
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 5.83
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 5.82
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 5.78
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 5.76
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 5.75
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.74
Human Treg IL-12 stimulation 5.73
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 5.7
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.69
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 5.67
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 5.67
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 5.66
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.64
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.64
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 5.6
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 5.57
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 5.56
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.55
Transcriptomic analyssis following EHMT1/2 inhibition 5.51
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 5.5
Identification of HOXB13 target genes responsive to BET inhibitors 5.5
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 5.5
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 5.48
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 5.47
Silencing p300 in MCF7 cells to study expression and alternative splicing 5.46
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 5.46
Real-time observation of light-controlled transcription in living cells 5.45
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.43
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.43
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 5.42
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 5.42
mRNA expression profile of Lymphocytes 5.41
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 5.4
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 5.38
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.3
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.29
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.29
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.27
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 5.27
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 5.24
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 5.24
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 5.21
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 5.21
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 5.19
N6-methyladenine DNA Modification in Glioblastoma 5.19
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 5.19
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 5.19
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 5.19
Global analysis of alternative splicing regulated by RBM10 5.17
3’ Uridylation Expands miRNA Target Repertoire 5.17
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 5.07
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.06
Genome-wide discovery of human splicing branchpoints 5.05
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 5.04
Biological effect of chronic mistranslation in mammalian cells 5.01
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 4.98
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.96
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.96
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 4.96
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 4.92
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.89
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 4.89
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.88
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.87
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.87
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 4.86
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.86
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 4.78
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.76
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 4.74
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 4.74
RNA sequencing of primary human platelets and in vitro cell lines 4.71
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.71
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.71
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 4.69
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.65
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.63
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 4.61
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 4.59
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 4.59
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.56
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.53
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.53
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 4.52
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 4.52
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 4.5
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.49
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.49
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 4.46
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 4.44
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.42
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 4.39
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.38
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.38
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.38
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 4.35
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.35
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 4.35
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 4.33
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 4.32
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.28
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 4.27
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 4.27
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.26
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.24
A prostate cancer chromatin interaction map 4.22
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 4.19
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.16
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 4.14
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 4.12
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 4.08
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 4.08
Integrin signaling regulates YAP/TAZ to control skin homeostasis 4.01
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.0
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.99
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.94
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.94
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 3.91
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.87
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.87
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.81
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.81
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.78
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 3.76
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.73
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 3.68
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.68
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.64
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 3.63
hnRNP C is a key regulator of protein synthesis in mitosis 3.59
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.57
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 3.55
Spliceosomal disruption of the non-canonical BAF complex in cancer 3.54
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.51
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 3.46
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 3.46
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.46
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 3.44
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 3.43
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 3.41
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 3.41
A map of gene expression in neutrophil-like cell lines 3.39
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 3.37
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.37
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 3.37
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 3.35
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.35
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.35
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.32
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 3.29
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 3.29
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.18
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 3.18
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 3.18
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 3.17
single cell RNA-seq from GM12878 (ENCSR673UIY) 3.12
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 3.11
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.08
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 3.04
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.03
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 3.02
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.02
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.99
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 2.91
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 2.91
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.9
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 2.86
The MEF2B Regulatory Network - RNA-seq data 2.85
The MEF2B Regulatory Network 2.85
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 2.84
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.84
K562 polyA RNA-Seq 2.79
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.78
Polarized B -cell functions 2.74
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.72
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.7
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.7
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.66
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 2.62
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 2.62
RNA sequencing of mechanically strained NHEKs and control NHEKs 2.59
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 2.57
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 2.57
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.57
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.57
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 2.56
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 2.53
RNA transcriptome analysis during HSV-1 infection 2.5
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 2.46
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.42
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.42
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.4
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.39
quanTIseq: quantifying immune contexture of human tumors 2.39
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 2.37
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 2.28
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.25
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.25
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.24
The cohesin complex prevents Myc-induced replication stress 2.22
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.22
Comparison of microRNA Profiling Platforms (HTS) 2.18
Comparison of microRNA Profiling Platforms 2.18
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.11
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 2.1
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 2.09
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 2.09
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 2.09
Gene expression signatures of innate lymphoid cells from human blood 2.08
Ribosome profiling upon inhibition of eIF4A 2.0
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 1.99
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 1.99
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.98
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.94
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 1.93
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.93
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.93
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 1.92
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.9
HBEC-shp53-PCHD7 1.87
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.86
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.82
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.81
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 1.8
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 1.77
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 1.77
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.76
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.7
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 1.66
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 1.66
p53 activity results in DNA replication fork processivity 1.65
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.63
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.62
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.62
RNA seq with AML (NB4) cells upon FTO inhibition 1.55
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.51
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 1.5
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.46
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 1.44
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 1.44
RNA-seq data 1.43
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.41
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.41
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.39
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.35
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.29
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.29
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.26
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.26
Human cells contain natural double-stranded RNAs with potential regulatory capacity 1.25
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 1.22
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 1.19
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.17
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.17
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.13
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.13
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.11
RNA-seq of IL-4 stimulated human keratinocytes 1.09
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 1.09
RNA-sequencing of healthy human skeletal myocytes 1.09
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.07
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 1.07
Transcriptome-wide modulation of splicing by the exon junction complex 1.07
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.06
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 1.05
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.02
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.02
Transcriptome landscape of HeLa response upon triamcinolone acetonide 1.0
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.99
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.99
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.94
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.93
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.92
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.9
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.9
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.88
Modeling Human Cancer-induced Cachexia (Human) 0.87
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.86
SNHG5 siRNA knock down in HCT116 cells 0.85
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.83
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.83
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.79
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 0.74
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.72
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.67
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.62
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.62
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.61
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.61
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.61
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.61
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.61
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.6
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.6
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.6
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 0.55
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.55
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.55
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.52
Genome-wide mapping of TEL-AML1 targets in acute leukemia 0.51
Myc activation coordinates gene transcription and protein translation responses 0.49
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.44
siRNA-mediated knockdown 0.44
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.43
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.42
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.39
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.33
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.32
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.31
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.31
RNA seq analysis of human Fetal and adult derived Enterospheres 0.26
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.2
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.2
A single-cell transcriptome atlas of the human pancreas 0.18
Transcriptome-wide response to synthetic chromatin protein PcTF 0.18
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.17
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.17
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.1
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.09
MARS Seq data from human cortical organoids 0.06
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 0.05
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.04
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.04
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.03
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.03
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.0
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation